- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02891499
Influence of Low-level Laser Therapy on Stability and Displacement of Orthodontic Miniscrew Implants
17. januar 2018 oppdatert av: Guido Artemio Marañón Vásquez, University of Sao Paulo
Effect of Low-level Laser Therapy on Stability and Displacement of Orthodontic Miniscrew Implants With Mediate and Immediate Force Application
The purpose of this study is to evaluate the effect of Low level laser therapy on stability and displacement of orthodontic miniscrew implants using two different force application protocols.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The aim of this study is to evaluate the effect of Low level laser therapy (LLLT) on stability and displacement of orthodontic miniscrew implants with mediate and immediate force application.
They will be assessed 48 miniscrew implants placed in patients in orthodontic treatment at the postgraduate clinical in Orthodontics, at School of Dentistry of Ribeirão Preto, University of São Paulo.
They will be randomly divided into 4 groups: 1- LLLT and immediate force application; 2- LLLT and force application 4 weeks after implantation; 3- immediate force application without LLLT and 4- force application 4 weeks after implantation without LLLT.
Orthodontic force of 150 gF will be applied for 3 months.
A low power laser device Therapy XT with a wavelength of 660 nm and output of 100 mW immediately after implantation (energy density: 4J/cm2), and 808 nm with 100 mW (energy density: 8J/cm2), every 48 hours for two weeks in the following applications will be used.
The stability will be assessed using Resonance Frequency Analysis (RFA) at three times: the implantation day (T1), one month (T2) and after 3 months of force application (T3).
Stability measures will be evaluated in Implant Stability Quotient (ISQ).
To assess the amount of miniscrew implant displacement, it will be used Cone Beam Computed Tomography (CBCT) at the beginning (CT1) and final of the application of orthodontic force (CT2).
Three-dimensional models will be created in specific programs and superimpositions of CT1 and CT2 will be used to measure the distance in millimeters between inicial and final position.
The evaluation will be carried out in three points: head of miniscrew implant (point C), thread (point R) and apex of miniscrew implant (point A).
The results will be statistically analyzed according to nature of the data and the significance level to be adopted will be 5%.
Studietype
Intervensjonell
Registrering (Faktiske)
29
Fase
- Ikke aktuelt
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
11 år og eldre (Barn, Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Patient with permanent teeth.
- Use of miniscrews in orthodontic planning.
- Miniscrews placed in the labial upper and lower posterior regions.
- Patient who agree to participate (Informed consent)
Exclusion Criteria:
- Patient with systemic disease.
- Patient with periodontal disease and/or inadequate oral hygiene.
- Use of drugs chronically.
- Patients that consume alcohol or tobacco.
- Use of fixed palatal or lingual orthodontic devices.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: LLLT + immediate force
Use of Low-level laser therapy and not mediate orthodontic force application (150 gF the day of the implantation).
|
|
Eksperimentell: LLLT + mediate force
Use of Low-level laser therapy and mediate orthodontic force application (150 gF 4 weeks after the day of the implantation).
|
Mediate force application protocol: orthodontic force application (150 gF) 4 weeks after the day of the implantation.
|
Ingen inngripen: Immediate force application
Not mediate orthodontic force application (150 gF the day of the implantation), without use of Low-level laser therapy.
|
|
Eksperimentell: Mediate force application
Mediate orthodontic force application (150 gF 4 weeks after the day of the implantation), without use of Low-level laser therapy.
|
Mediate force application protocol: orthodontic force application (150 gF) 4 weeks after the day of the implantation.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change from baseline miniscrew implant stability at 1 and 3 months of force application.
Tidsramme: T1: Implantation day; T2: after 1 month; and, T3: after 3 months of force application.
|
It will be used a Resonance frequency analysis (RFA) equipment.
Stability measures will be evaluated using a unique unit of measure: Implant stability quotient (ISQ).
All groups will be evaluated the day of the implantation (T1) and after 1 month (T2).The last stability measure (T3) will be done 3 months after the implantation day in the groups without mediate force application, and 4 months after the implantation day in the groups with mediate force application.
|
T1: Implantation day; T2: after 1 month; and, T3: after 3 months of force application.
|
Change from baseline miniscrew implant position at 3 months of force application.
Tidsramme: CT1: Implantation day; and, CT2: 3 months of orthodontic force application.
|
It will be used Cone Beam Computed tomography (CBCT).
Three-dimensional models will be created in specific programs and superimpositions of CT1 and CT2 will be used to measure the distance in millimeters between initial and final position.
|
CT1: Implantation day; and, CT2: 3 months of orthodontic force application.
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Guido A Marañón Vásquez, DDS, University of Sao Paulo
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. mars 2016
Primær fullføring (Faktiske)
1. februar 2017
Studiet fullført (Faktiske)
1. august 2017
Datoer for studieregistrering
Først innsendt
23. august 2016
Først innsendt som oppfylte QC-kriteriene
31. august 2016
Først lagt ut (Anslag)
7. september 2016
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
18. januar 2018
Siste oppdatering sendt inn som oppfylte QC-kriteriene
17. januar 2018
Sist bekreftet
1. januar 2018
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- USaoPaulo-1
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Low-level laser therapy
-
Yolo Medical Inc.Fullført
-
Shanghai Eye Disease Prevention and Treatment CenterFullført
-
Nantes University HospitalFullførtKlasse II hund | Intermaxillær styrke | Elastikk II | Multi Fasteners Ortodontisk behandlingFrankrike
-
Karadeniz Technical UniversityFullført
-
Heath SkinnerFullførtStrålingsdermatittForente stater
-
Federal University of Health Science of Porto AlegreUkjentKardiovaskulære sykdommer
-
Federal University of Rio Grande do SulFullførtTemporomandibulær lidelse
-
Hospital Israelita Albert EinsteinFullført
-
Legacy Health SystemFullførtPerifer nevropatiForente stater
-
Merck Sharp & Dohme LLCFullførtDengue virus | Dengue sykdomForente stater, Australia, Canada, Finland, Tyskland, Israel, Taiwan